Journal Mobile Options
Table of Contents
Vol. 37, No. 1, 2004
Issue release date: January–February 2004
Section title: Original Paper
Psychopathology 2004;37:8–19
(DOI:10.1159/000077014)

Neurocognitive Models of Schizophrenia: A Neurophenomenological Critique

Gallagher S.
Department of Philosophy, Cognitive Sciences Program, University of Central Florida, Orlando, Fla., USA

Do you have an account?

Register and profit from personalized services (MyKarger) Login Information

Please create your User ID & Password





Contact Information









I have read the Karger Terms and Conditions and agree.

Register and profit from personalized services (MyKarger) Login Information

Please create your User ID & Password





Contact Information









I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in

Buy

  • FullText & PDF
  • Unlimited re-access via MyKarger (new!)
  • Unrestricted printing, no saving restrictions for personal use
  • Reduced rates with a PPV account
read more

Direct: USD 38.00
Account: USD 26.50

Select

Rent/Cloud

  • Rent for 48h to view
  • Buy Cloud Access for unlimited viewing via different devices
  • Synchronizing in the ReadCube Cloud
  • Printing and saving restrictions apply

Rental: USD 8.50
Cloud: USD 20.00

Select

Subscribe

  • Automatic perpetual access to all articles of the subscribed year(s)
  • Unlimited re-access via Subscriber Login or MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more

Subcription rates


Select


Article / Publication Details

First-Page Preview
Abstract of Original Paper

Received: 12/19/2002
Accepted: 12/4/2003
Published online: 3/18/2004

Number of Print Pages: 12
Number of Figures: 1
Number of Tables: 0

ISSN: 0254-4962 (Print)
eISSN: 1423-033X (Online)

For additional information: http://www.karger.com/PSP

Abstract

This paper argues that Frith’s (1992) account of the positive symptoms of schizophrenia in terms of a disruption of metarepresentational self-monitoring is inadequate in several specific ways. More generally, this paper argues against top-down explanations for the loss of the sense of agency in such symptoms. In addition, even if delusions of control might be explained by problems involved in motor control mechanisms involving efference copy and comparators, there are good reasons why the same model cannot explain thought insertion. In place of such neurocognitive explanations, the author develops a neurophenomenological explanation for the loss of the sense of agency and the misattribution of actions and thoughts to others in such symptoms.


  

Author Contacts

Shaun Gallagher
Department of Philosophy, Colbourn Hall 411
University of Central Florida
Orlando, FL 32816-1352 (USA)
Tel. +1 407 823 5409, Fax +1 407 823 6658, E-Mail gallaghr@mail.ucf.edu

  

Article Information

Received: December 19, 2002
Accepted after revision: December 4, 2003
Published online: February 24, 2004
Number of Print Pages : 12
Number of Figures : 1, Number of Tables : 0, Number of References : 52

  

Publication Details

Psychopathology (International Journal of Descriptive and Experimental Psychopathology, Phenomenology and Psychiatric Diagnosis)
Founded 1897 as ‘Monatsschrift für Psychiatrie und Neurologie’
Official Journal of the World Psychiatric Association (WPA), Section of Clinical Psychopathology and Section of Classification and Diagnostic Assessment

Vol. 37, No. 1, Year 2004 (Cover Date: January-February 2004)

Journal Editor: C. Mundt, Heidelberg; E. Gabriel, Vienna; J.E. Mezzich, New York, N.Y.
ISSN: 0254–4962 (print), 1423–033X (Online)

For additional information: http://www.karger.com/psp


Article / Publication Details

First-Page Preview
Abstract of Original Paper

Received: 12/19/2002
Accepted: 12/4/2003
Published online: 3/18/2004

Number of Print Pages: 12
Number of Figures: 1
Number of Tables: 0

ISSN: 0254-4962 (Print)
eISSN: 1423-033X (Online)

For additional information: http://www.karger.com/PSP


Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.